Domains targeting keyword astrazeneca
Keyword astrazeneca was used in the provided list of websites.
Number of websites/domains displayed: 90
Results found: 322
Websites discovered:
Astmahttp://pageoverview.com/website-report/astma.ee
- Expected expiration: August 20th in 2018
- Creation date: July 4th in 2010
- Renew date: July 6th in 2017
- Google Analytics: 19961404-8
AstraZeneca Medical Education Grantshttp://pageoverview.com/website-report/astrazenecagrants.com
- Expected expiration: December 8th in 2018
- Creation date: December 8th in 2004
- Renew date: December 4th in 2017
Asthma research and Symbicort SMARThttp://pageoverview.com/website-report/symbicort.com
Symbicort SMART delivered via the Symbicort Turbuhaler delivers medication to maintain asthma control and treat symptoms
- Expected expiration: February 8th in 2018
- Creation date: February 8th in 1999
- Renew date: February 4th in 2017
AstraZeneca Germanyhttp://pageoverview.com/website-report/astrazeneca.de
- Renew date: December 17th in 2012
Homehttp://pageoverview.com/website-report/eosinophilasthma.com
Eosinophilic asthma can have a serious long-term impact on asthma severity and control in your patients. Sign up for updates on eosinophilic asthma from AstraZeneca.
- Expected expiration: January 10th in 2019
- Creation date: January 10th in 2017
- Renew date: January 6th in 2018
Lavitacon il cancro al polmone: le esperienze dei pazientihttp://pageoverview.com/website-report/lavitacon.it
Siamo accomunati dalla malattia. Le storie di chi, come noi, ha il cancro al polmone ci sostengono nel nostro percorso. Segui una community di persone come te.
- Expected expiration: November 16th in 2018
- Creation date: November 16th in 2016
- Renew date: December 2nd in 2017
FluMist® Quadrivalent (Influenza Vaccine Live, Intranasal) | Flu Vaccinehttp://pageoverview.com/website-report/flumistquadrivalent.com
Help protect against seasonal flu with FluMist® Quadrivalent (Influenza Vaccine Live, Intranasal) - the flu vaccine that starts working in the nose.
- Expected expiration: December 6th in 2017
- Creation date: December 6th in 2011
- Renew date: December 2nd in 2016
TUDORZA® PRESSAIR® (aclidinium bromide inhalation powder) | HCP Sitehttp://pageoverview.com/website-report/tudorzahcp.com
Healthcare professional information on TUDORZA PRESSAIR (aclidinium bromide inhalation powder), an anticholinergic indicated for the long-term maintenance treatment of bronchospasm associated with COPD.
- Expected expiration: May 10th in 2020
- Creation date: May 10th in 2012
- Renew date: March 24th in 2016
AstraZeneca Russiahttp://pageoverview.com/website-report/astrazeneca.ru
- Expected expiration: March 19th in 2018
- Creation date: March 18th in 2001
- Renew date: May 28th in 2017
AstraZenecahttp://pageoverview.com/website-report/astrazeneca.co.kr
AstraZeneca Francehttp://pageoverview.com/website-report/astrazeneca.fr
- Expected expiration: April 5th in 2018
- Creation date: October 23rd in 2008
- Renew date: April 1st in 2017
アストラゼネカ株式会社 What science can do サイエンスにできることhttp://pageoverview.com/website-report/astrazeneca.co.jp
アストラゼネカは、「サイエンスの限界に挑み、患者さんの人生を変える医薬品をお届けする」ことをミッションとする製薬会社です。「オンコロジー」「循環器・代謝疾患」「呼吸器・自己免疫疾患」を3大重点疾患領域として研究開発を積極的に進めています。
- Creation date: December 25th in 1998
- Renew date: January 19th in 1999
PI-Centralhttp://pageoverview.com/website-report/azpicentral.com
- Expected expiration: July 8th in 2017
- Creation date: July 8th in 2014
- Renew date: January 29th in 2016
astrazeneca.cnhttp://pageoverview.com/website-report/astrazeneca.cn
- Creation date: March 17th in 2003
- Expected expiration: March 17th in 2018
Koronaar.ee avalehthttp://pageoverview.com/website-report/koronaar.ee
koronaar
- Expected expiration: July 9th in 2018
- Creation date: July 8th in 2010
- Renew date: May 25th in 2017
- Google Analytics: 19961404-4
utils-astrazeneca.comhttp://pageoverview.com/website-report/utils-astrazeneca.com
- Expected expiration: November 7th in 2017
- Creation date: November 7th in 2011
- Renew date: February 26th in 2016
「胸やけ」「呑酸(どんさん)」などでお困りではありませんか?|胸やけ・呑酸.jphttp://pageoverview.com/website-report/muneyake-donsan.jp
逆流性食道炎について第一三共株式会社とアストラゼネカ株式会社が紹介するウェブサイトです。
- Expected expiration: October 31st in 2017
- Creation date: October 12th in 2011
- Renew date: November 1st in 2016
PULMICORT FLEXHALER® (budesonide inhalation powder, 90 mcg & 180 mcg)http://pageoverview.com/website-report/pulmicortflexhalertouchpoints.com
Official health care professional website for PULMICORT FLEXHALER® (budesonide inhalation powder, 90 mcg & 180 mcg), a maintenance asthma treatment for patients 6 years of age and older.
- Expected expiration: October 15th in 2017
- Creation date: October 15th in 2009
- Renew date: October 11th in 2016
AstraZeneca UK - Research-Based BioPharmaceutical Companyhttp://pageoverview.com/website-report/astrazeneca.co.uk
Our focus is on developing new medicines that make a meaningful difference to patients’ lives, and the UK is right at the heart of our efforts to do that.
- Expected expiration: December 8th in 2017
- Creation date: December 8th in 1998
- Renew date: December 4th in 2016
Nexium.jphttp://pageoverview.com/website-report/nexium.jp
- Expected expiration: July 31st in 2017
- Creation date: July 29th in 2005
- Renew date: August 1st in 2016
COPD Treatment | TUDORZA® PRESSAIR® (aclidinium bromide inhalation powder)http://pageoverview.com/website-report/tudorza.com
Patient information on TUDORZA PRESSAIR (aclidinium bromide inhalation powder), an anticholinergic indicated for the long-term maintenance treatment of bronchospasm associated with COPD.
- Expected expiration: March 4th in 2020
- Creation date: March 4th in 2011
- Renew date: March 31st in 2016
AstraZeneca - Research-Based BioPharmaceutical Companyhttp://pageoverview.com/website-report/astrazeneca.com
AstraZeneca is a global, science-led biopharmaceutical business and our innovative medicines are used by millions of patients worldwide.
- Expected expiration: December 7th in 2017
- Creation date: December 8th in 1998
- Renew date: December 3rd in 2016
- Google Analytics: 9600290-2
阿斯利康中国http://pageoverview.com/website-report/astrazeneca.com.cn
作为一家以创新为驱动的全球性生物制药企业,阿斯利康始终相信“科学,激发无限可能”,并将科学作为一切工作的重中之重。
- Creation date: June 2nd in 1999
- Expected expiration: June 2nd in 2018
AstraZeneca Canadahttp://pageoverview.com/website-report/astrazeneca.ca
- Expected expiration: April 2nd in 2018
- Creation date: October 9th in 2000
- Renew date: March 19th in 2017
Vivre Avec un cancer du sein métastatiquehttp://pageoverview.com/website-report/vivreavec.eu
Vivre Avec un cancer du sein métastatique est votre point commun. Découvrez les histoires de personnes touchées par ce cancer et partagez votre expérience.
����ɂȂ��Ă� -����̎��Â��A���̐l�u�炵���v�����̂Ȃ��ŁB-http://pageoverview.com/website-report/az-oncology.jp
乳がん・前立腺がん・肺がんを中心としたがん患者さんやご家族の体験談や、高額療養費制度・がん医療用語・市民公開講座などの情報をご紹介します。
- Expected expiration: July 31st in 2017
- Creation date: July 7th in 2005
- Renew date: August 1st in 2016
AstraZeneca Italyhttp://pageoverview.com/website-report/astrazeneca.it
- Expected expiration: March 28th in 2018
- Creation date: February 9th in 2000
- Renew date: April 13th in 2017
AstraZeneca UShttp://pageoverview.com/website-report/astrazeneca-us.com
- Expected expiration: December 9th in 2017
- Creation date: December 10th in 1998
- Renew date: December 5th in 2016
FARXIGA® (dapagliflozin) | Treatment for Type 2 Diabetes Mellitus in Adultshttp://pageoverview.com/website-report/farxiga-hcp.com
FARXIGA® (dapagliflozin) is an SGLT2 inhibitor indicated for patients with type 2 diabetes mellitus. Explore the science behind FARXIGA.
- Expected expiration: September 23rd in 2017
- Creation date: September 23rd in 2013
- Renew date: September 19th in 2016
Asthma Treatment | PULMICORT FLEXHALER® (budesonide inhalation powder, 90 mcg & 180 mcg)http://pageoverview.com/website-report/pulmicortflexhaler.com
Official patient site. Learn about PULMICORT FLEXHALER a medication for the maintenance treatment of asthma symptoms in adults and children 6 years or older. Find information about the inhaler and side effects and a How to Use FLEXHALER video.
- Expected expiration: November 16th in 2017
- Creation date: November 16th in 2006
- Renew date: November 12th in 2016
astrazeneca.nethttp://pageoverview.com/website-report/astrazeneca.net
- Expected expiration: December 7th in 2017
- Creation date: December 8th in 1998
- Renew date: December 3rd in 2016
Bipolar Disorder Medication | SEROQUEL XR® (quetiapine fumarate)http://pageoverview.com/website-report/seroquelxr.com
Find information to better understand major depressive disorder (MDD), bipolar disorder, bipolar depression, and SEROQUEL XR® (quetiapine fumarate).
- Expected expiration: March 29th in 2018
- Creation date: March 29th in 2007
- Renew date: March 25th in 2017
Recipes, Activities, Treatment and Support for your Health Conditionshttp://pageoverview.com/website-report/fit2me.com
Fit2Me™ a FREE food and activity program that's custom fit to you and your health challenges. Plus, there's personalized treatment information and support!
- Expected expiration: August 15th in 2017
- Creation date: August 15th in 2011
- Renew date: August 11th in 2016
Welcome to AstraZeneca AZ&Me | AZ&Me™ Prescription Savings Programhttp://pageoverview.com/website-report/azandmeapp.com
The AZandMe Prescription Savings program is designed to help qualifying patients, including those who receive their medications through participating healthcare facilities. This site will guide you through the AZ&Me application process to see if you are eligible for the program. Find out if you qualify to receive AstraZeneca medicines at no cost.
- Expected expiration: October 20th in 2017
- Creation date: October 20th in 2009
- Renew date: October 16th in 2016
digital-astrazeneca.comhttp://pageoverview.com/website-report/digital-astrazeneca.com
- Expected expiration: June 29th in 2018
- Creation date: June 29th in 2015
- Renew date: June 25th in 2017
SALUD MENTAL ESPAÑAhttp://pageoverview.com/website-report/feafes.org
299 asociaciones y 19 federaciones para mejorar la calidad de vida y derechos de las personas con problemas de salud mental y sus familias.
- Expected expiration: October 8th in 2017
- Creation date: October 8th in 2010
- Renew date: September 27th in 2016
- Google Analytics: 23843657-1
- Google Plus Account: 105010163903468795927
MOVANTIK® (naloxegol) | Mu-Opioid Receptor Antagonisthttp://pageoverview.com/website-report/movantikhcp.com
Official health care professional Web site for MOVANTIK® (naloxegol) tablets, for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain.
- Expected expiration: February 14th in 2019
- Creation date: February 14th in 2014
- Renew date: January 29th in 2016
RSV Protection | Respiratory Syncytial Virus Informationhttp://pageoverview.com/website-report/rsvprotection.com
Think you know about RSV Disease? Learn more about Respiratory Syncytial Virus, risk factors, and protection tips for your baby & infant.
- Expected expiration: March 30th in 2018
- Creation date: March 30th in 1999
- Renew date: March 26th in 2017
肺がんとともに生きる | アストラゼネカhttp://pageoverview.com/website-report/haigan-tomoni.jp
「肺がんとともに生きる」は、肺がんではないかと心配な方、肺がんと向き合う方やそのご家族の方などを対象としております。肺がんとともに生きるすべての方にお役立ていただける情報の提供を目指します。
- Expected expiration: October 31st in 2018
- Creation date: October 7th in 2015
- Renew date: November 1st in 2017
Farmacêutico em Focohttp://pageoverview.com/website-report/farmaceuticoemfoco.com.br
Site com foco científico, atualizado com temas do dia a dia do profissional Farmacêutico: Antibióticos, Anestesia, Anestésicos, Biosegurança, Diabetes, Asma, DPOC, Quimioterapia, Infecção Hospitalar
- Expected expiration: May 24th in 2019
- Creation date: May 24th in 2007
- Renew date: April 28th in 2017
PARP inhibitor for Advanced Ovarian Cancer | LYNPARZA® (olaparib)http://pageoverview.com/website-report/lynparzahcp.com
LYNPARZA® (olaparib) is the first and only PARP inhibitor approved in 2 distinct settings: maintenance for recurrent ovarian cancer and following 3 or more lines of prior chemotherapy.
- Expected expiration: December 4th in 2018
- Creation date: December 4th in 2014
- Renew date: November 30th in 2017
AZ Immuno-Oncology: Our Vision in Immuno-Oncologyhttp://pageoverview.com/website-report/azimmuno-oncology.com
Find out more about PD-L1 inhibition, CTLA-4 inhibition, other Immuno-Oncology pathways like OX40 agonism, Anti-CEA BiTE, STAT3 inhibition, and PD-1 inhibition.
- Expected expiration: June 25th in 2020
- Creation date: June 25th in 2015
- Renew date: January 29th in 2016
AstraZeneca Spainhttp://pageoverview.com/website-report/astrazeneca.es
- Google Plus Account: 100361028938140154919
FASENRA™ (benralizumab) Subcutaneous Injection 30 mghttp://pageoverview.com/website-report/fasenra.com
FASENRA™ (benralizumab) is a prescription medicine used with other asthma medicines for the maintenance treatment of asthma in adults whose asthma is not controlled with their current asthma medicines.
- Expected expiration: August 1st in 2018
- Creation date: August 1st in 2016
- Renew date: September 13th in 2017
Adult Type 2 Diabetes Treatment | XIGDUO XRhttp://pageoverview.com/website-report/xigduoxr.com
Learn about XIGDUO® XR (dapagliflozin/metformin HCl extended-release) tablets, for the treatment of type 2 diabetes in adults.
- Expected expiration: September 2nd in 2018
- Creation date: September 2nd in 2014
- Renew date: August 29th in 2017
Acid Reflux Medication | NEXIUM® (esomeprazole magnesium)http://pageoverview.com/website-report/purplepill.com
Discover NEXIUM, the Purple Pill, which offers 24-hour heartburn relief caused by acid reflux disease. Ask your doctor if NEXIUM may be right for you.
- Expected expiration: October 29th in 2017
- Creation date: October 29th in 1999
- Renew date: October 25th in 2016
����Onlinehttp://pageoverview.com/website-report/zutsu-online.jp
頭痛で悩むアナタに、頭痛の原因と解消法をお届けします。頭痛に悩む方のためのWebサイト。
- Expected expiration: December 31st in 2017
- Creation date: December 18th in 2006
- Renew date: January 1st in 2017
Cholesterol Medicine | CRESTOR® (rosuvastatin calcium)http://pageoverview.com/website-report/crestor.com
Information about CRESTOR® (rosuvastatin calcium), a prescription cholesterol medicine that helps lower LDL cholesterol when diet and exercise alone are not enough.
- Expected expiration: October 26th in 2017
- Creation date: October 27th in 1994
- Renew date: October 22nd in 2016
astrazeneca-annualreports.comhttp://pageoverview.com/website-report/astrazeneca-annualreports.com
- Expected expiration: October 30th in 2017
- Creation date: October 30th in 2007
- Renew date: October 26th in 2016
IRESSA® (gefitinib) Treatmenthttp://pageoverview.com/website-report/iressa-usa.com
IRESSA® (gefitinib) is a treatment for patients.
- Expected expiration: June 8th in 2018
- Creation date: June 8th in 2015
- Renew date: June 4th in 2017
MOVANTIK® (naloxegol) | Opioid Induced Constipation Treatmenthttp://pageoverview.com/website-report/movantik.com
Official Web site for MOVANTIK® (naloxegol) tablets, for the treatment of opioid-induced constipation (OIC) in adult patients with chronic non-cancer pain.
- Expected expiration: September 25th in 2017
- Creation date: September 25th in 2013
- Renew date: September 20th in 2016
Homehttp://pageoverview.com/website-report/iressa.com
Official site of IRESSA (gefitinib), indicated in Europe for the treatment of adults with locally advanced or metastatic NSCLC with activating mutations of EGFR-TK across all lines of therapy.
- Expected expiration: August 13th in 2017
- Creation date: August 13th in 1999
- Renew date: August 9th in 2016
E-Asthma is Eosinophilic Asthmahttp://pageoverview.com/website-report/easthma.com
Is your severe asthma e-asthma? Read about e-asthma (eosinophilic asthma) and find out more about severe asthma and eosinophils.
- Expected expiration: August 30th in 2018
- Creation date: August 30th in 2001
- Renew date: July 31st in 2017
FARXIGA® (dapagliflozin) | Type 2 Diabetes Medication for Adultshttp://pageoverview.com/website-report/farxiga.com
FARXIGA® (dapagliflozin) is an adult type 2 diabetes medication used with diet and exercise to improve glycemic control.
- Expected expiration: August 27th in 2017
- Creation date: August 27th in 2013
- Renew date: August 23rd in 2016
VascTrachttp://pageoverview.com/website-report/vasctrac-astrazeneca.azurewebsites.net
ONGLYZA® (saxagliptin) | Adult Type 2 Diabetes Medicationhttp://pageoverview.com/website-report/onglyza.com
Read information about ONGLYZA® (saxagliptin), an adult type 2 diabetes medication used with diet and exercise to help reduce A1C levels.
- Expected expiration: January 19th in 2019
- Creation date: January 19th in 2006
- Renew date: January 15th in 2018
TAGRISSO™ (osimertinib) | Official Global Sitehttp://pageoverview.com/website-report/tagrisso.com
Learn more about TAGRISSO (osimertinib) and its benefits, side effects and efficacy for the treatment of patients with EGFRm T790M mutation-positive NSCLC.
- Expected expiration: April 24th in 2018
- Creation date: April 24th in 2015
- Renew date: April 20th in 2017
フォシーガ.jphttp://pageoverview.com/website-report/forxiga.jp
選択的SGLT2阻害剤-2型糖尿病治療剤-の「フォシーガ(forxiga)」のサイト、フォシーガ.jpへようこそ 「フォシーガ.jp」では、フォシーガの製品情報や糖尿病治療に関する様々な情報をお届けします。
- Expected expiration: October 31st in 2017
- Creation date: October 29th in 2011
- Renew date: November 1st in 2016
Career opportunities at AstraZeneca | AstraZeneca Careershttp://pageoverview.com/website-report/astrazenecacareers.com
Interested in career opportunities with AstraZeneca? Search current pharmaceutical job openings at AstraZeneca and apply now!
- Expected expiration: August 1st in 2017
- Creation date: August 1st in 2000
- Renew date: July 28th in 2016
- Google Analytics: 53609256-2
BRILINTA® (ticagrelor) tablets | Heart Attack Treatmenthttp://pageoverview.com/website-report/brilinta.com
Read about BRILINTA® (ticagrelor) tablets, a prescription medication for heart attack treatment, or severe chest pain, also known as unstable angina.
- Expected expiration: April 21st in 2018
- Creation date: April 21st in 2005
- Renew date: April 17th in 2017
Guide to Better Breathing | Breathe In & Outhttp://pageoverview.com/website-report/breatheinout.com
Get your free e-book for breathing tips, exercises, and more, plus receive bonus content personalized to your needs from our added feature BREATHABLE.
- Expected expiration: August 27th in 2017
- Creation date: August 27th in 2015
- Renew date: August 23rd in 2016
BEVESPI AEROSPHERE® (glycopyrrolate/ formoterol fumarate) Inhalation Aerosolhttp://pageoverview.com/website-report/bevespiaerosphere.com
BEVESPI AEROSPHERE® (glycopyrrolate/ formoterol fumarate) is a long‐term, maintenance treatment of airflow obstruction in patients with COPD, including chronic bronchitis and/or emphysema.
- Expected expiration: August 13th in 2018
- Creation date: August 13th in 2015
- Renew date: August 9th in 2017
LYNPARZA® (olaparib) | Ovarian Cancer Treatmenthttp://pageoverview.com/website-report/lynparza.com
LYNPARZA®(olaparib) is a type of targeted therapy for ovarian cancer called a PARP inhibitor. LYNPARZA may be used at different stages of ovarian cancer treatment.
- Expected expiration: February 10th in 2019
- Creation date: February 10th in 2014
- Renew date: January 29th in 2016
Greece - AstraZenecahttp://pageoverview.com/website-report/astrazeneca.gr
AstraZeneca - Greece - Discover the ground-breaking work we are doing in Greece at AstraZeneca.com
High Blood Pressure Medication | TOPROL-XLhttp://pageoverview.com/website-report/azhypertensionbrands.com
- Expected expiration: November 19th in 2018
- Creation date: November 19th in 2013
- Renew date: November 19th in 2013
Adult Type 2 Diabetes Treatment | XIGDUO XRhttp://pageoverview.com/website-report/xigduo.com
Learn about XIGDUO® XR (dapagliflozin/metformin HCl extended-release) tablets, for the treatment of type 2 diabetes in adults.
- Expected expiration: February 21st in 2018
- Creation date: February 21st in 2012
- Renew date: February 17th in 2017
British Toxicology Societyhttp://pageoverview.com/website-report/thebts.org
- Expected expiration: October 13th in 2018
- Creation date: October 13th in 2000
- Renew date: October 5th in 2017
- Google Analytics: 85676986-1